Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Gilead To License New Hepatitis C Drug To Indian Generic Drug Manufacturers

Reuters: Gilead to license hepatitis C drug to lower-cost manufacturers in India
“Gilead Sciences plans to license its breakthrough hepatitis C drug Sovaldi to a number of Indian generic pharmaceutical manufacturers, allowing for lower-priced sales of the medication in that developing nation, according to the company…” (Beasley, 2/6).